ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Rinvoq® shows positive results in rheumatoid arthritis post-hoc analysis
November 10, 2021AbbVie has announced new results from a post-hoc analysis of the Phase III SELECT-BEYOND clinical trial evaluating Rinvoq® (upadacitinib; 15mg, once daily) in patients with moderate... -
Novartis, Cadila Healthcare lead digital marketing space for ankylosing spondylitis in India: GlobalData
May 21, 2021Novartis and Cadila Healthcare are the only companies to offer support to AS patients through digital channels, finds GlobalData. -
NICE publishes final guidance backing Jyseleca for rheumatoid arthritis
January 22, 2021The National Institute for Health and Care Excellence (NICE) has published its final appraisal determination (FAD) recommending the use of Gilead Sciences and Galapagos’ Jyseleca (filgotinib) for the treatment of rheumatoid arthritis (RA). -
Janssen's Tremfya approved for active psoriatic arthritis
November 27, 2020The European Commission has approved Janssen’s Tremfya (guselkumab) as a first-in-class treatment for active psoriatic arthritis (PsA).
Pharma Sources Insight January 2025
